Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Filings indexed 2,266 across all filing types
Latest filing 2021-10-12 Regulatory Filings
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
110年9月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report listing company codes and names, with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. It does not contain financial statements, detailed analysis, or any specific report content. The length is short (699 characters), and it appears to be a regulatory or informational summary rather than a full report or announcement of a meeting, voting, or financial results. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others that require substantive financial data. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-10-12 Chinese
公告本公司增加持有被控股公司家數
Regulatory Filings Classification · 95% confidence The document is a short announcement (679 characters) from a company disclosing an increase in the number of subsidiaries it controls. It includes details such as the board resolution date, reasons for the increase, names and business categories of the subsidiaries, and shareholding percentages. There is no financial data, no detailed report, and no mention of financial results or regulatory filings beyond this disclosure. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate structure changes that does not fit into more specific categories like MANG (management changes) or CAP (capital updates).
2021-10-06 Chinese
公告本公司董事會決議私募普通股發行價格相關事宜
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding a board resolution on private placement of common shares, including details such as the number of shares, pricing, pricing basis, and use of funds. It is a specific update on capital raising activities and share issuance, not a full financial report or earnings release. The document length is short (1429 characters) and it contains detailed information about a private placement decision by the board. This fits the definition of a Capital/Financing Update (CAP) rather than a full Annual Report, Interim Report, or Regulatory Filing. Therefore, the appropriate classification is CAP.
2021-10-06 Chinese
本公司董事會通過取得富康活力醫藥股份有限公司51%之股權
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (4164 承業醫) reporting the board's approval to acquire 51% equity in another company. It details the transaction specifics such as share quantity, price, total amount, counterparties, and related accounting and approval information. The content is focused on a capital acquisition transaction and does not contain financial statements or comprehensive financial analysis. The document length is short (1866 characters) and is a formal disclosure of a corporate transaction rather than a full report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2021-10-06 Chinese
公告本公司減少持有被控股公司家數
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (4164 承業醫) regarding a reduction in the number of its controlled subsidiaries. It includes details about the reason for the reduction, the name of the subsidiary, business category, and shareholding percentage. The document is short (715 characters) and does not contain financial statements or detailed financial data. It is an announcement about a corporate structural change rather than a financial report or detailed management discussion. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-06 Chinese
110年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and stock transactions by insiders, including directors, senior management, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of it being a full financial report, earnings release, or regulatory certification. The document is a typical insider shareholding notification, which corresponds to the category 'Director's Dealing' (DIRS). The document length is sufficient and contains substantive data on insider shareholdings and transactions.
2021-10-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.